Open-Label, Prospective, Multicentre, Phase I/II Study of AOP2014, a Novel PEG-Proline-Interferon Alpha-2b in Patients with Polycythemia Vera: Update from an Ongoing StudyHeinz Gisslinger, Josef Thaler, Franz-Josef Tarmann et al.|Blood|2011Cited by 2